SAMPLE TABLES
TABLE 1 LONG-ACTING INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY REGION, 2013 – 2020( USD MILLION)
REGION 2013 2014 2015-e 2020-p
CAGR( 2015 – 2020)
NORTH AMERICA |
xx. x |
xx. x |
xx. x |
xx. x |
xx. x % |
EUROPE |
xx. x |
xx. x |
xx. x |
xx. x |
xx. x % |
ASIA-PACIFIC |
xx. x |
xx. x |
xx. x |
xx. x |
xx. x % |
ROW |
xx. x |
xx. x |
xx. x |
xx. x |
xx. x % |
TOTAL |
xx. x |
xx. x |
xx. x |
xx. x |
xx. x % |
Sources: WHO, OECD, EHN, the World Bank, U. S. Census Bureau, Offices of National Statistics( U. K.), Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, and MarketsandMarkets Analysis
TABLE 2 U. S.: HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT, 2013 – 2020( USD MILLION)
PRODUCT 2013 2014 2015-e 2020-p
CAGR( 2015 – 2020)
INSULIN ANALOGS & BIOSIMILARS xx. x xx. x xx. x xx. x xx. x % HUMAN INSULIN BIOLOGICS xx. x xx. x xx. x xx. x xx. x % TOTAL xx. x xx. x xx. x xx. x xx. x %
Sources: WHO, OECD, EHN, the World Bank, U. S. Census Bureau, Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, and MarketsandMarkets Analysis
TABLE 3 EUROPE: HUMAN INSULIN MARKET SIZE, BY COUNTRY, 2013 – 2020( USD MILLION)
COUNTRY / REGION 2013 2014 2015-e 2020-p
CAGR( 2015 – 2020)
GERMANY |
xx. x |
xx. x |
xx. x |
xx. x |
xx. x % |
FRANCE |
xx. x |
xx. x |
xx. x |
xx. x |
xx. x % |
U. K. |
xx. x |
xx. x |
xx. x |
xx. x |
xx. x % |
ROE |
xx. x |
xx. x |
xx. x |
xx. x |
xx. x % |
TOTAL |
xx. x |
xx. x |
xx. x |
xx. x |
xx. x % |
Sources: WHO, OECD, EHN, the World Bank, Offices of National Statistics( U. K.), Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, and MarketsandMarkets Analysis
sales @ marketsandmarkets. com www. marketsandmarkets. com
25